- Home
- VIRC vs NMRA Comparison
VIRC vs NMRA Comparison
Compare VIRC & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- NMRA
- Stock Information
- Founded
- VIRC 1950
- NMRA 2019
- Country
- VIRC United States
- NMRA United States
- Employees
- VIRC N/A
- NMRA N/A
- Industry
- VIRC Industrial Specialties
- NMRA
- Sector
- VIRC Consumer Discretionary
- NMRA
- Exchange
- VIRC Nasdaq
- NMRA Nasdaq
- Market Cap
- VIRC 128.3M
- NMRA 234.5M
- IPO Year
- VIRC N/A
- NMRA 2023
- Fundamental
- Price
- VIRC $8.10
- NMRA $2.08
- Analyst Decision
- VIRC
- NMRA Buy
- Analyst Count
- VIRC 0
- NMRA 8
- Target Price
- VIRC N/A
- NMRA $7.14
- AVG Volume (30 Days)
- VIRC 75.3K
- NMRA 2.2M
- Earning Date
- VIRC 09-08-2025
- NMRA 08-06-2025
- Dividend Yield
- VIRC 1.23%
- NMRA N/A
- EPS Growth
- VIRC N/A
- NMRA N/A
- EPS
- VIRC 1.25
- NMRA N/A
- Revenue
- VIRC $253,259,000.00
- NMRA N/A
- Revenue This Year
- VIRC $0.81
- NMRA N/A
- Revenue Next Year
- VIRC $4.56
- NMRA N/A
- P/E Ratio
- VIRC $6.52
- NMRA N/A
- Revenue Growth
- VIRC N/A
- NMRA N/A
- 52 Week Low
- VIRC $7.79
- NMRA $0.61
- 52 Week High
- VIRC $18.50
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- VIRC 49.15
- NMRA 70.06
- Support Level
- VIRC $7.92
- NMRA $1.70
- Resistance Level
- VIRC $8.52
- NMRA $2.85
- Average True Range (ATR)
- VIRC 0.32
- NMRA 0.32
- MACD
- VIRC 0.03
- NMRA 0.05
- Stochastic Oscillator
- VIRC 42.47
- NMRA 58.08
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.